Neurologic clinical trial -EFC16035 Perseus

Neurologic

Status:

Open/Enrolling

ClinicalTrials.gov:

NCT04458051

EFC16035 Perseus

Drug

SAR442168

Phase

Phase III

Condition

Primary Progressive Multiple Sclerosis

Keywords

Primary Progressive Multiple Sclerosis | PPMS | MS | Multiple Sclerosis